| Literature DB >> 12134470 |
Abstract
The classic workup of a patient for possible PA is revisited in light of the vanishing Schilling test. The vagaries of testing for B12 and blocking antibodies are reexamined. The advantages and disadvantages of newer tests such as MMA and serum gastrin levels are catalogued. At this juncture in the evolution of new test strategies, there is a considerable controversy regarding the significance of high MMA levels in the face of normal B12 levels, particularly in the elderly. Hopefully, this controversy will soon be resolved and the newer crop of tests will be proven and accepted in the workplace. Still, the words of Alexander Pope spring to mind: "Be not the first by whom the new are tried, Nor yet the last to lay the old aside."Entities:
Mesh:
Substances:
Year: 2002 PMID: 12134470 DOI: 10.1016/s0272-2712(01)00003-8
Source DB: PubMed Journal: Clin Lab Med ISSN: 0272-2712 Impact factor: 1.935